Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Endothelin A (ET A ) receptor blockade has prevented vascular remodeling in aldosterone and salt-induced hypertension. To evaluate effects of the ET A receptor antagonist, BMS 182874, compared with the aldosterone antagonist, spironolactone, on vascular remodeling in aldosterone-infused rats not exposed to a high salt diet, Sprague-Dawley rats were infused subcutaneously with aldosterone (0.75 μg/h) and treated with BMS 182874 (40 mg · kg −1 · d −1 ), spironolactone, or hydralazine (both 25 mg · kg −1 · d −1 ) while receiving a normal salt diet for 6 weeks. Aldosterone increased systolic BP ( P <0.01), plasma endothelin (3.33±0.32 versus 1.85±0.40 pmol/L in control, P <0.05), systemic oxidative stress as shown by plasma thiobarbituric acid–reacting substances and vascular nicotinamide adenine dinucleotide phosphate (NADPH) activity. Aldosterone increased small artery media thickness (17.7±0.9 versus 13.6±0.8 μm in control, P <0.05) and media/lumen ratio (7.6±0.4 versus 5.5±0.4% in control, P <0.05), with growth index of 21% indicating hypertrophic remodeling. Laser confocal microscopy showed increased collagen and fibronectin deposition and intercellular adhesion molecule-1 (ICAM-1) content in the vessel wall of aldosterone-infused rats. The 3 treatments lowered BP, although hydralazine was slightly less effective. BMS 182874 and spironolactone decreased oxidative stress, normalized the hypertrophic remodeling, decreased collagen and fibronectin deposition, and reduced ICAM-1 abundance in the vascular wall of aldosterone-infused rats, whereas hydralazine only reduced NADPH activity in aorta but did not affect the remaining parameters. Vascular remodeling of small arteries occurs in aldosterone-infused rats exposed to a normal salt diet and may be mediated in part by ET-1 via stimulation of ET A receptors. Endothelin blockade may exert beneficial effects on vascular remodeling, fibrosis, oxidative stress, and adhesion molecule expression in aldosterone-induced hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Alexander, R. W. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.155 · Cited by 785
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754
Farquharson, C. A. J., & Struthers, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.6.594 · Cited by 532
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
Schnackenberg, C. G., Welch, W. J., & Wilcox, C. S. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.59 · Cited by 498
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Khanna, K., Zuckerman, A., & Stier, C. T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.451 · Cited by 496
Chen, X., Touyz, R. M., Park, J. B., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.094005 · Cited by 410
Self-citationNADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat
Beswick, R. A., Dorrance, A. M., Leite, R., & Webb, R. C. (2001) · Hypertension · doi:10.1161/hy1101.093423 · Cited by 347
Hatakeyama, H., Miyamori, I., Fujita, T., Takeda, Y., Takeda, R., & Yamamoto, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51084-5 · Cited by 316
Münzel, T., Kurz, S., Rajagopalan, S., Thoenes, M., Berrington, W. R., Thompson, J. A., Freeman, B. A., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118935 · Cited by 314
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Zuckerman, A., & Stier, C. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.232 · Cited by 310
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.
Lombès, M., Oblin, M. E., Gasc, J. M., Baulieu, E. E., Farman, N., & Bonvalet, J. P. (1992) · Circulation Research · doi:10.1161/01.res.71.3.503 · Cited by 309
Li, J. S., Larivière, R., & Schiffrin, E. L. (1994) · Hypertension · doi:10.1161/01.hyp.24.2.183 · Cited by 286
Self-citationLarivière, R., Thibault, G., & Schiffrin, E. L. (1993) · Hypertension · doi:10.1161/01.hyp.21.3.294 · Cited by 282
Self-citationVascular Hypertrophy and Remodeling in Secondary Hypertension
Rizzoni, D., Porteri, E., Castellano, M., Bettoni, G., Muiesan, M. L., Muiesan, P., Giulini, S. M., & Agabiti-Rosei, E. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.785 · Cited by 238
Excess ldosterone Is Associated With Alterations of Myocardial Texture in Primary Aldosteronism
Rossi, G. P., Di Bello, V., Ganzaroli, C., Sacchetto, A., Cesari, M., Bertini, A., Giorgi, D., Scognamiglio, R., Mariani, M., & Pessina, A. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000023182.68420.eb · Cited by 234
Role of Endothelin-1 in Hypertension
Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.876 · Cited by 195
Self-citationPlasma Endothelin in Human Essential Hypertension
Schiffrin, E. L., & Thibault, G. E. L. (1991) · American Journal of Hypertension · doi:10.1093/ajh/4.4.303 · Cited by 193
Self-citationInteractions between endothelin-1 and the renin–angiotensin–aldosterone system
Rossi, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00110-8 · Cited by 180
Yura, T., Fukunaga, M., Khan, R., Nassar, G., Badr, K. F., & Montero, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00596.x · Cited by 174
Oxidative Stress Increases Synthesis of Big Endothelin-1 by Activation of the Endothelin-1 Promoter
Kahler, J. P., Mendel, S., Weckmüller, J., Orzechowski, H., Mittmann, C., Köster, R., Paul, M., Meinertz, T., & Münzel, T. F. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1178 · Cited by 156
Chatziantoniou, C., Boffa, J. J., Ardaillou, R., & Dussaule, J. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2132 · Cited by 134
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1
Park, J. B., & Schiffrin, E. L. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02291-9 · Cited by 127
Self-citationPark, J. B., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1444 · Cited by 119
Self-citationSchiffrin, E. L., Larivière, R., Li, J. S., Sventek, P., & Touyz, R. M. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.769 · Cited by 113
Self-citationSeccia, T. M., Belloni, A. S., Kreutz, R. H., Paul, M., Nussdorfer, G. G., Pessina, A. C., & Rossi, G. P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02860-7 · Cited by 104
Raij, L. R. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.767 · Cited by 104
Schiffrin, E. L., Larivière, R., Li, J., & Sventek, P. (2008) · Journal of Vascular Research · doi:10.1159/000159151 · Cited by 93
Self-citationLarivière, R., Deng, L. Y., Day, R. W., Sventek, P., Thibault, G., & Schiffrin, E. L. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(95)91263-0 · Cited by 87
Self-citationLow-Dose Angiotensin II Increases Free Isoprostane Levels in Plasma
Haas, J. A., Krier, J. D., Bolterman, R. J., Juncos, L. A., & Romero, J. C. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.983 · Cited by 81
Li, J., Knafo, L., Turgeon, A., Garcia, R., & Schiffrin, E. L. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.1.h88 · Cited by 74
Self-citationRossi, G. P., Sacchetto, A., Rizzoni, D., Bova, S., Porteri, E., Mazzocchi, G., Belloni, A. S., Bahçelioğlu, M., Nussdorfer, G. G., & Pessina, A. C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.949 · Cited by 53
Intengan, H. D., He, G., & Schiffrin, E. L. (1998) · Hypertension · doi:10.1161/01.hyp.32.4.770 · Cited by 44
Self-citationPu, Q., Touyz, R. M., & Schiffrin, E. L. (2002) · Journal of Hypertension · doi:10.1097/00004872-200205000-00025 · Cited by 30
Self-citationBradbury, R. H., Bath, C., Butlin, R. J., Dennis, M. R., Heys, C., Hunt, S. J., James, R., Mortlock, A. A., Sumner, N. F., TANG, E. K. Y., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9604585 · Cited by 30
Effects of endothelins on renin secretion from rat kidneys
SCHOLZ, H., Krämer, B. K., Hamann, M., Götz, K.-H., & Kurtz, A. (1995) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1995.tb09962.x · Cited by 21
Mechanisms of ET-1 potentiation of angiotensin II stimulation of aldosterone production
Cozza, E. N., & Gómez-Sánchez, C. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.2.e179 · Cited by 21
GENE EXPRESSION OF ENDOTHELIN-1 (ET-1) AND RELEASE OF MATURE PEPTIDE BY ACTIVATED HUMAN NEUTROPHILS
Cambiaggi, C., Mencarelli, M., Muscettola, M., & Grasso, G. (2001) · Cytokine · doi:10.1006/cyto.2001.0865 · Cited by 20
Cited by
Xiao, L., & Harrison, D. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.01.013 · Cited by 545
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Wilcox, C. S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00250.2005 · Cited by 481
Renal Damage in Primary Aldosteronism: Results of the PAPY Study
Rossi, G. P., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., Matterello, M.-J., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000230444.01215.6a · Cited by 470
Gill, P. S., & Wilcox, C. S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1597 · Cited by 457
Oxidative Stress and Hypertension
Harrison, D. G., & Gongora, M. C. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.015 · Cited by 445
Metadata
- Authors
- Pu, Q., Neves, M. F., Virdis, A., Touyz, R. M., & Schiffrin, E. L.
- Venue
- Hypertension
- Published
- 2003-07
- Volume
- 42
- Issue
- 1
- Pages
- 49-55
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2160393148
- Cited by
- 255
- References
- 41
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.